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CHRONIC ABDOMINAL PAIN 
 
General Outcome 
The students should be able to list and describe different conditions 
which can cause chronic abdominal pain, manage the main investigations dif-
ferentiating it’s causes, know modern strategies of diagnostics and treatment of 
chronic abdominal pain, manage psychosocial presentations of chronic ab-
dominal pain. 
Student must know:  
 Modern standarts of diagnostics and treatment of patients with chronic 
abdominal pain.  
 Differential diagnosis of different causes of abdominal pain. 
 Drawing the plan of appropriate investigations. 
 Role of instrumental and laboratory methods of investigations.  
 Strategy of management of patients with chronic abdominal pain de-
pending on etiological factors. 
 Conservative and surgical treatment.  
 Following management of patients. 
 Prognosis and working capacity. 
 
The evaluation of any patient with a complaint of abdominal pain is 
challenging. Abdominal pain can be benign and self-limited or a harbinger of a 
serious life-threatening disease. Chronic abdominal pain poses a particularly 
challenging clinical problem. Not only is the management of chronic abdominal 
pain a frequently daunting task, but also the possibility of overlooking a struc-
tural or organic disorder is always a concern. Many disorders discussed else-
where in this text can produce chronic abdominal pain (table 1). Many of these 
diagnoses require careful consideration and clinical interrogation, in addition to 
appropriate diagnostic testing, to discern whether the entity is indeed the cause 
of the patient's pain. Diagnosis of a functional gastrointestinal disorder is gen-
erally considered once potential causes of organic chronic abdominal pain have 
been confidently excluded. Although the causes of chronic abdominal pain are 
varied, the pathophysiologic pathways that produce chronic pain are common 
to many of them. Functional abdominal pain syndrome (FAPS) serves as a 
model to illustrate many of the complex issues involved in caring for patients 








Table 1.  
Differential Diagnosis of Chronic or Recurrent Abdominal Pain 
 
Structural (or Organic) Disorders  
Inflammatory: appendicitis, celiac disease, eosinophilic gastroenteri-
tis, fibrosing mesenteritis (mesenteric panniculitis), inflammatory bowel dis-
eases, pelvic inflammatory diseases, primary sclerosing cholangitis 
Vascular: celiac artery syndrome, mesenteric ischemia, superior mes-
enteric artery syndrome 
Metabolic: diabetic neuropathy, familial Mediterranean fever, heredi-
tary angioedema, porphyria,  
Neuromuscular: anterior cutaneous nerve entrapment syndrome, myo-
fascial pain syndrome, slipping rib syndrome, thoracic nerve radiculopathy 
Other: abdominal adhesions, abdominal neoplasms, anaphylaxis, 
chronic pancreatitis, endometriosis, gallstones, hernias, intestinal malrota-
tion, intestinal obstruction, lactose intolerance, peptic ulcer disease, small 
intestinal and pelvic lipomatosis  
Functional Gastrointestinal Disorders: biliary pain (gallbladder or sphincter 
of Oddi dysfunction, functional abdominal pain syndrome, functional (nonulcer) 
dyspepsia, gastroparesis, irritable bowel syndrome, levator ani syndrome  
 
DEFINITION AND CLINICAL APPROACH 
Abdominal pain is considered chronic when it has been occurring con-
stantly or intermittently over at least six months. Abdominal pain is considered 
acute when it has been occurring for several days and subacute when it has 
been occurring more than several days but less than 6 months. These arbitrary 
definitions are often helpful when formulating a differential diagnosis. The 
clinician initially must adopt a broad-based approach, which necessarily be-
comes more focused as the evaluation ensues. Importantly, although typical 
patterns of presentation are useful to remember, some patients, especially im-
munosuppressed and older persons, may present with atypical features.  
 
STEP-BY-STEP DIAGNOSTIC APPROACH 
Assessment includes 4 major components:  
1. History. 
2. Physical examination.  
3. Psychosocial assessment. 
4. Investigations. 
1. The sensitivity of history and physical examination are low. Epigas-
tric pain and gastroduodenal pathology, RUQ pain and hepatobiliary pathology, 
and suprapubic pain and gynaecological pathology are the only findings with 
specificity >50%. The physical examination should be integrated with findings 
from the history and other collateral information to focus the diagnostic work-
up on possible diagnoses. 
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Pain may arise from any system, including the genitourinary, gastroin-
testinal, and gynecologic tracts. The aetiology of chronic abdominal pain is so 
wide that only the more common causes can be covered here. 
Anyhow, the initial step in evaluating a patient with chronic abdominal 
pain is to elicit a detailed history from the patient. The chronology of the pain, 
including its abruptness of onset and duration, and its location and possible 
radiation should be determined. Visceral pain emanating from the digestive 
tract is perceived in the midline, because of the relatively symmetrical bilateral 
innervation of the organs, but is diffuse and poorly localized. Referred pain is 
ordinarily located in the cutaneous dermatomes that share the same spinal cord 
level as the affected visceral inputs. The patient should be questioned about the 
intensity and character of the pain, with the understanding that these parameters 
are subjective. The patient's perception of precipitating, exacerbating, or miti-
gating factors may be useful when diagnostic possibilities are considered.  
Symptoms assessment: The localisation of pain from abdominal vis-
cera, especially the small bowel, is imprecise. Most of the digestive tract is 
perceived in the midline due to its symmetric innervation. Exceptions include 
pathologies of the ascending/descending colon and gallbladder, which may 
present with one-sided pain due to unilateral innervation. The location of pain 
and the patient's perception of the anatomical distribution can sometimes help 
to narrow the differential diagnosis and guide diagnostic evaluation:  
Epigastric and upper abdominal pain can indicate oesophageal (e.g., gas-
tro-oesophageal reflux), stomach (e.g., gastritis), duodenal (e.g., ulcer), gall-
bladder (e.g., cholecystitis), or pancreatic (e.g., pancreatitis) origin. 
Lower abdominal pain can indicate large bowel involvement, and later-
alisation may help to distinguish between descending/sigmoid colon (e.g., left-
sided diverticulitis) and ascending/caecum (e.g., Crohn's ileocolitis), or appen-
dix (e.g., appendicitis).  
Pelvic pain can suggest gynaecological origin (e.g., ovarian cysts, PID) 
or chronic pelvic pain syndrome (e.g., interstitial cystitis, endometriosis, ure-
thral syndrome, or changes and dysfunction of the pelvic muscles).  
Localised point of maximal pain in the anterior abdomen can indicate 
chronic abdominal wall pain or abdominal cutaneous nerve entrapment syn-
drome. Localised pain can also arise at specific sites such as the kidneys, uret-
ers, and ovaries, or from a source of focal peritoneal irritation. 
Information about exacerbating and relieving factors may provide fur-
ther clues: Pain made worse by eating (postprandial pain) may indicate gastric 
ulcer, chronic pancreatitis, gallstones, abdominal ischaemia (also called ab-
dominal angina), or functional disorders such as irritable bowel syndrome, 
functional dyspepsia, or postprandial distress syndrome (postprandial fullness). 
Pain relieved by eating suggests duodenal peptic ulcer disease. Pain relieved by 
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defecation may indicate irritable bowel syndrome. Pain associated with men-
strual cycle suggests gynaecological origin. Additional symptoms of dyspare-
unia, dysmenorrhoea, pain with defecation, and infertility suggest endometrio-
sis. Pain associated with urinary urgency and frequent urination suggests inter-
stitial cystitis. Pain in the anterior abdomen that is accentuated by physical 
activity can indicate chronic abdominal wall pain or abdominal cutaneous nerve 
entrapment syndrome.  
Pain due to organic conditions (e. g., ulcers, cholelithiasis, pancreatitis) 
is generally circumscribed, unlike pain due to functional disorders. Radiation of 
the pain to the shoulder indicates cholelithiasis, to the inguinal and genital re-
gion nephrolithiasis, to the back, pancreatic diseases, aortic aneurysm, or ulcer 
penetration). 
Increased pain while lying down occurs with reflux disease and pancreas 
diseases. More intense pain while standing occurs with hernias. Increased pain 
with movement indicates abdominal wall processes (such as trauma), vertebro-
genic pain (such as discopathy), or reflux disease. 
When initially attempting to determine whether the patient's pain is 
caused by an organic or functional process, the clinician should search for clues 
in the patient's history and physical examination that support or refute the diag-
nosis of a progressive, serious, chronic underlying illness. Such features in the 
history include fever, night sweats, appetite change, weight loss, and nocturnal 
awakening.  
2. Physical examination. The physical examination should first fo-
cus on the vital signs. Fever, tachycardia, tachypnoea, and hypotension suggest 
an acute illness requiring urgent evaluation. A head and neck examination is 
useful for non-specific signs of intra-abdominal pathology, including: temporal 
wasting, sunken eyes, and prominent clavicles, suggesting significant weight 
loss; dry mucosal membranes, indicating volume depletion; icteric sclera, indi-
cating hepatobiliary disease; pale conjunctiva, suggesting anemia. Peripheral 
vascular disease is suggested by diminished pulses and may co-exist with intes-
tinal angina or mesenteric ischaemia. Pain on deep inspiration suggests referred 
pain from the lungs or RUQ/LUQ pain. 
The abdominal examination should use a combination of inspection, 
auscultation, percussion, and palpation. The most critical step for a patient with 
an acute exacerbation of chronic abdominal pain is to ascertain promptly 
whether a surgical abdomen is present. Although most causes of chronic ab-
dominal pain do not require immediate surgical treatment, a complication re-
lated to a disease process ordinarily associated with chronic abdominal pain 
may present acutely (e.g., intestinal perforation in a patient with inflammatory 
bowel disease). Furthermore, a patient who has experienced chronic abdominal 
pain may present with acute pain related to another disease process (e.g., acute 
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mesenteric ischemia in a patient with underlying irritable bowel syndrome 
[IBS]). The abdomen should be auscultated to detect an abdominal bruit, be-
cause the presence of a bruit may suggest chronic mesenteric ischemia (intesti-
nal angina). Abdominal palpation for the presence of organomegaly, masses, 
and ascites and examination for hernias are particularly pertinent.  
In some cases examination is unremarkable, but rebound tenderness, guard-
ing, or tenderness on palpation require urgent consideration. Precise localisation of 
the pain in the anterior abdomen with positive Carnett's sign (i.e., increase of 
pain/tenderness on re-palpation during contraction of abdominal muscles, suggest-
ing abdominal wall origin) can help to differentiate between abdominal wall pain 
and intra-abdominal pathology. Careful rectal examination and pelvic examination 
are part of a thorough evaluation. Bleeding, diarrhoea, discharge/mucus, tenderness, 
rectal masses, or obstruction can provide important additional clues for underlying 
disease processes. In females with pelvic/lower abdominal pain, gynaecological 
examination should be considered. 
Other physical findings that suggest an underlying organic illness in-
clude signs of malnutrition (e.g., muscle wasting or edema), vitamin deficien-
cies, or extraintestinal processes (e.g., arthropathy or skin changes). Although 
not entirely specific, the closed eyes sign is often seen in patients with FAPS. 
Physical examination should include skin and mouth for non-specific findings 
such as ulcers, vesicles, angiomata, bleeding or bruising, or specific lesions 
(e.g., erythema nodosum). 
The pelvic girdle, lower back, and thorax (ribs and spine) should be ex-
amined, since this may yield clues about symptoms wrongly attributed to ab-
dominal organs.  
3. Psychosocial assessment. The association between chronic ab-
dominal pain and a history of PTSD, abuse, somatisation, anxiety, and depres-
sion is well recognised. Evaluation of psychosocial factors can help to deter-
mine an appropriate management plan and minimise unnecessary investiga-
tions. Affective disturbance can both result from and contribute to the experi-
ence of chronic pain. Clinical presentation, symptom severity, and response to 
treatment can all vary according to mental state abnormalities. Symptom fluc-
tuations and mental state should be monitored closely. 
4. Investigations.Specific algorithms for the diagnostic work-up of 
chronic abdominal pain do not exist. Appropriate investigations should be tai-
lored to history and examination findings and be made on a case-by-case basis. 
In the absence of alarm features, laboratory and imaging tests should be ordered 
in a conservative and cost-effective manner.  
1. Laboratory 
The laboratory evaluation can be helpful, but the clinician must first dis-
till pertinent facets of the history and physical examination to focus the labora-
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tory assessment. Injudicious use of laboratory testing is costly and can confuse 
the clinical picture and even lead to complications. It is worth emphasizing that 
an abnormal laboratory test result does not necessarily prove causality in rela-
tion to a patient's chronic pain syndrome. The clinician must exercise the ut-
most discretion when ordering and interpreting the results of laboratory tests. 
The patient should be asked about previous investigations as, owing to the 
chronicity of their symptoms, many patients will already have been investigated 
and existing information may be available for review.  
Standard laboratory tests include:  
 FBC with differential, to screen for infection or anaemia. The platelet 
count and ESR may signify an inflammatory process. 
 Serum electrolytes, glucose, creatinine, and urea for metabolic causes.  
 Liver function tests, lipase, and amylase, particularly in patients with 
upper abdominal pain.  
 Urine analysis and urine culture to help exclude UTI and interstitial 
cystitis. 
Additional laboratory tests based on the individual case include: 
 Stool tests for culture, ova and parasites, and Giardia antigen should be 
done if bacterial, parasitic, or protozoal cause of abdominal pain is suspected.  
 Urine or serum pregnancy test: this should also be done prior to radio-
graphic or endoscopic investigations.  
 Serology testing for Helicobacter pylori in patients with upper GI 
symptoms, including early satiety and epigastric discomfort (i.e., dyspeptic 
symptoms).  
 Vaginal swabs, pap smears, beta-human chorionic gonadotropin, pros-
tate-specific antigen, and urine cytology can be helpful in certain cases with 
pelvic and lower abdominal pain. 
2. Endoscopy 
Endoscopic and imaging studies have important roles in diagnosing and 
excluding many causes of chronic abdominal pain. Upper endoscopy and 
colonoscopy, as well as capsule endoscopy, may be indicated in selected cases. 
Available imaging investigations include barium and radionuclide studies, 
ultrasonography, computed tomography, magnetic resonance imaging, positron 
emission tomography (PET), and conventional angiography. The indications 
for each of these radiologic investigations differ, as do their potential to clarify 
an individual clinical situation.  
All patients >50 years old with abdominal pain should have a GI tract 
endoscopy.  
Colonoscopy is indicated if the pain is in the lower abdomen and/or it is 
associated with changes in bowel habit.  
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Upper endoscopy is indicated if the pain is localised in the upper abdo-
men, particularly if other upper GI symptoms (early satiety, nausea, vomiting) 
are present. There are no guidelines suggesting when these tests in younger 
(<50 years old) patients should be ordered.  
3. Imaging 
Further investigations depend on the clinical findings.  
Upper abdominal ultrasound may be indicated to evaluate RUQ or epi-
gastric pain, particularly if elevated liver or pancreatic enzymes are found.  
Pelvic abdominal ultrasound and trasvaginal and/or transrectal ultra-
sound is indicated for evaluating lower abdominal pain. 
CT scanning can help to evaluate dilated intestinal loops; exclude partial 
intestinal obstruction; detect abnormalities in other abdominal organs (e.g., 
pancreas, liver, kidneys); identify inflammatory processes (e.g., inflammatory 
bowel disease, diverticulitis, abscesses); and investigate retroperitoneal or pel-
vic masses.  
If all investigations are negative, the likely diagnosis is a functional GI 
disorder. The diagnosis of specific functional disorders depends on the pres-
ence and characteristics of additional associated symptoms. Irritable bowel 
syndrome and functional dyspepsia are the most common causes of chronic 
abdominal pain in adults.  
If the pain is located in the abdomen rather than the pelvic region, and is 
not related to food intake or defecation, a diagnosis of functional abdominal 
pain syndrome (FAPS) may be appropriate. FAPS, also called chronic idio-
pathic abdominal pain or chronic functional abdominal pain, describes recur-
rent, continuous or near-continuous abdominal pain not related to gut function, 
associated with loss of daily activities, and present for >6 months. Like other 
functional GI disorders, FAPS cannot be explained by structural or metabolic 
disorders, and it is believed to be related to altered pain perception and pain 
modulation circuits.  
 
CAUSES OG CHRONIC ABDOMINAL PAIN ACCORDING  
TO THEIR ORIGIN 
 
Pain Originating from the Stomach and Small Intestine 
Distribution. Pain originating from the stomach and small intestine can 
be generally classified as follows:  
 chronic gastritis 
 functional gastric disorders (gastric irritation) 
 ulcerous disease (duodenal ulcer, gastric ulcer) 
 gastric carcinoma 
 rare disorders 
 complaints secondary to general diseases. 
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Diagnosis. The differential diagnosis is based on the medical history, 
clinical findings, imaging (endoscopy, radiologic examination), and biopsy 
with a histologic analysis. 
A detailed medical history is particularly important in gastric diseases. 
Functional stomach disorders (irritable stomach) are characterized by their 
relatively indefinite character. They generally occur irregularly and have no 
periodicity. The pain is frequently accentuated immediately after eating. 
Endoscopy is most important for diagnosis of obscure epigastric pain, dys-
phagia, heartburn, and gastrointestinal bleeding. Another indication is an unclear 
iron deficiency anemia. Radiologic examinations are helpful, particularly in cases 
of paraesophageal hiatus hernia, motility disorders, Zenker diverticulitis, external 
compression, or stenoses that cannot be detected endoscopically. 
Endosonography can be used to detect intramural processes, espe-
cially the extent and depth of infiltration of neoplasms, as well as lymph 
node metastases. 
Chronic Gastritis 
Type A, B and C gastritis must be distinguished. 
Type A Gastritis. Type A gastritis (autoimmune gastritis) primarily af-
fects the gastric body and fundus. It is caused by autoimmune processes. It is 
typically associated with pernicious anemia. Autoantibodies against parietal 
cells and intrinsic factor are typical. Gastrin is increased. The risk of develop-
ment of a gastric carcinoma is significantly increased in chronic-atrophic type 
A gastritis. Endoscopic surveillance is therefore indicated. 
Type B Gastritis. Type B gastritis (bacterial gastritis) is primarily local-
ized in the gastric antrum and is typically caused by Helicobacter pylori (Hp). 
It is more common than type A gastritis and is associated with gastric ulcers, 
duodenal ulcer, and mucosa-associated lymphoid tissue (MALT) lymphoma. 
Type C Gastritis. Type C gastritis (chemical gastritis) is caused by 
chemical irritation, i. e., reflux of bile (bile gastritis) or duodenal contents (re-
flux gastritis) and most importantly drugs, in particular use of NSAIDs (NSAID 
gastropathy). 
Rare Cases of Gastritis. Rare, chronic forms of gastritis are lympho-
cytic, eosinophilic, and granulomatous gastritis. 
Diagnosis. Chronic gastritis can only be confirmed by histology. There 
is no clear relationship to typical clinical symptoms. The majority of patients 
with histologically demonstrated chronic gastritis are asymptomatic. 
 
Functional Dyspepsia 
Continuous epigastric pain, loss of appetite, nausea, and frequent vomit-
ing are the main symptoms. Eating tends to exacerbate the symptoms and there 
is generally no periodicity or diurnal rhythm. This information from the medi-
cal history generally distinguishes this complaint from an ulcer. The lack of the 
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typical endoscopic changes with irritable stomach is decisive for differential 
diagnosis. 
Ulcers 
The central feature of ulcers is infection with Helicobacter pylori (Hp). 
There has been a radical change in the understanding of ulcers. The eradication 
of the Hp infection in patients with ulcers not only heals the acute lesion but 
generally prevents recurrence and complications of ulcers. Only about 10% of 
patients infected with Hp in industrialized countries develop an ulcer, but 95% 
of patients with a duodenal ulcer are infected with Hp. 
This indicates that Hp infection alone is not sufficient to cause an ulcer. 
Hp generates conditions that, together with additional risk factors, cause an 
ulcer: stress, smoking, and a genetic predisposition. 
Helicobacter pylori Detection. The presence of Hp can be confirmed 
 histologically by Giemsa or Warthin−Starry staining of gastric antrum 
biopsies 
 by urease activity either with a fast urease test in the biopsy specimen 
or an exhalation test with 13C or 14Clabeled urea 
 by culture from gastric antrum biopsies  
 by serology: serology is, however, not generally useful, because Hp 
colonizes approximately 10% of persons under 30 and approximately 60% of 
persons of 60 years, while only 10% of infected persons develop an ulcer. 
Clinical Features and Differential Diagnosis. Strongly localized pain 
is characteristic for ulcers, as compared to irritable stomach and acute gas-
tritis. In acute gastritis a diffuse pain upon palpation is generally present in 
the epigastric region. Many patients with ulcers can point to the exact loca-
tion of the spontaneous pain and the pain upon palpation. The maximum 
pain is to the left of the abdominal mid-line with gastric ulcers and to the 
right with duodenal ulcers. 
The character of the pain is important in differential diagnosis versus 
biliary colic (period and diurnal rhythm of the pain). The pain characteristics 
and the diurnal rhythm typical for ulcers are particularly important. A biliary 
colic lasts for one to three days, ulcer pain for three to five weeks. Ulcer pain 
generally disappears after eating within a few minutes while biliary pain does 
not. Ulcer pain is virtually never accompanied by nausea while nausea is very 
frequent with biliary diseases. Appetite is not affected, unlike with gastritis and 
carcinoma. If the character of the pain is not typical in spite of other signs of an 
ulcer, the possibility of complications must be considered: 
 with continuous and back pain: penetration 
 with nausea and vomiting: stenosis. 
An ulcer episode, like acute gastritis, can be triggered by stress situa-
tions (surgery, serious trauma), alcohol abuse, or drugs (including NSAIDs). 
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Ulcers occur at all ages, particularly after puberty. Carcinoma incidence in-
creases with age but can also be observed in 20- to 30-year-olds. 
Diagnosis. The mainstay of ulcer diagnosis is endoscopy. Multiple biop-
sies from and around the ulcer are key for differentiating benign from malig-
nant stomach ulcers. 
Radiologic diagnosis is no longer common, but when performed, an 
ulcer niche, may be visible under tangential setting as a contrast agent 
bulge in the region of the gastric curvature. The ulcer niche is visible as a 
persistent contrast spot in the direct frontal view. About 85% of ulcer 
niches are on the minor curvature of the stomach. The remaining 15% occur 
at the major curvature, the dorsal wall (back pain), and in the pyloric re-
gion. Gastric carcinomas can also form niches. Indirect ulcer signs are 
spastic retractions on the wall opposite the ulcer, referred to as ulcer fin-
gers. They are not specific for ulcers, because they are also observed with 
various tumors. After healing an hourglass stomach may develop, which 
results from shrinkage of the minor curvature by scar tissue and spastic 
retraction of the major curvature. 
Duodenal Ulcer. More than 95% of duodenal ulcers occur in the duo-
denal bulb. Untreated they are characterized by spontaneous healing and recur-
rence. 60% of untreated cases recur within one year and 80−90% within two 
years. 95−100% are associated with Hp infection. 
The main symptom is pain, that typically occurs 90 minutes to three 
hours postprandial and is relieved by eating (food relief). Asymptomatic ulcers 
are common.  
Complications are penetration, particularly into the pancreas (constant 
pain in the back), stomach outlet obstruction (pain increased postprandially, 
vomiting), perforation, and hemorrhage. 
Postbulbar ulcers are rare. The clinical symptoms correspond to the clas-
sical duodenal ulcer, but postbulbar ulcers bleed more frequently. 
Gastric Ulcer. The peak incidence of gastric ulcers is in the sixth dec-
ade of life and thus about 10 years later than with duodenal ulcers. Men are 
affected more frequently than women. Benign gastric ulcers are most com-
monly localized adjacent to the corpus−antrum border. Gastric erosions and 
ulcers are often caused by NSAIDs. Gastric ulcers not associated with NSAIDs 
are generally caused by Hp infection. The pain is less typical than in duodenal 
ulcers and increases after eating. Nausea and vomiting occur even without 
gastric outlet obstruction, in contrast to the duodenal ulcer. Asymptomatic 
courses are common. 
It is important to note that gastric ulcers, much more commonly than 
duodenal ulcers, can be caused by carcinoma. Histologic diagnosis is therefore 
mandatory and the healing must be monitored endoscopically. 
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Ulcer Associated with Other Diseases. Duodenal ulcer, is frequently 
observed in patients with: cirrhosis of the liver, chronic obstructive jaundice, 
chronic pancreatitis, chronic lung disease, especially emphysema, chronic renal 
insufficiency, general arteriosclerosis, polycythemia vera, hyperparathyroidism, 
systemic mastocytosis. 
Gastric ulcers, are frequently observed: with NSAID use, in smokers, 
after chemotherapy. 
Use of aspirin and other NSAIDs causes gastric ulcers much more fre-
quently than duodenal ulcers. Ulcers and strictures of the small and large intes-
tine also occur. 
Stress-induced Erosions. Stress-induced erosions and ulcers are often 
multiple and frequently occur in areas of the stomach with high activity, after 
shock, massive burns (Curling ulcer), sepsis, and after serious trauma. 
Hemorrhage is frequent, particularly in patients on respirators and with 
coagulation disorders. 
Cushing Ulcer. Gastric ulcers frequently occur after brain trauma, brain 
surgery, or in patients with elevated brain pressure (Cushing ulcer). 
Zollinger−Ellison Syndrome. Ulcers are a complication of Zollin-
ger−Ellison syndrome. Gastrinomas (most frequently originating from non-β-
pancreatic islet cells or duodenal G cells), through overproduction of gastrin, 
increase secretion of gastric acid and are thus responsible for the formation of 
ulcers. Zollinger−Ellison syndrome should be considered in the following situa-
tions: 
 peptic ulcers with atypical localization (esophagus, postbulbus, je-
junal), multiple occurrence (approximately 10%), and resistance to treatment. 
 aqueous diarrhea, with or without steatorrhea, with or without hypo-
kalemia and its consequences.  
 gastric hypersecretion and increased serum gastrin levels. 
 prominent gastric mucosa folds, as with Menetrier disease 
 25% of cases are associated with multiple endocrine adenomatosis 
type I (Wermer syndrome). Zollinger−Ellison syndrome must be considered in 
patients with signs of hyperparathyroidism or hypophyseal tumor. The family 
medical history is particularly important in view of the inheritance. 
 Fasting serum gastrin levels are elevated. Massive hyperchlorhydria 
and hypergastrinemia (> 1000 pg/mL) are diagnostic. Increased serum gastrin 
levels are also found in achlorhydria (e. g., pernicious anemia, after vagotomy, 
stomach resection). In Zollinger−Ellison syndrome serum gastrin levels in-
crease significantly in response to calcium infusion or after secretin administra-
tion. These provocation tests are useful for identification of Zollinger−Ellison 
syndrome in patients with borderline serum gastrin levels (200−1000 pg/mL). 
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Late Complications of Ulcer Disease. Pyloric Stenosis. Pyloric steno-
sis is a late complication of chronic recurring ulcers. The character of ulcer pain 
is changed and loss of appetite occurs. Feelings of fullness and discomfort after 
meals, which are not present in uncomplicated ulcers indicate stenosis. A steno-
sis is very likely with vomiting that relieves or cures late pain and with vomit-
ing of food from the previous day. If endoscopic examination identifies empty 
stomach secretion and food 12 hours after eating, this supports the diagnosis. 
Food and liquid retention can often be detected by sonography. The di-
agnosis is confirmed radiologically by slow pyloric passage, dilatation of the 
stomach, and marked dilution of the contrast agent by stomach secretion and 
food residues. The nature of the pyloric stenosis (benign or malignant) can 
generally be defined by endoscopy and histology. 
Gastric Carcinoma. Epidemiology and Risk Factors. 85% of malignant 
tumors in the stomach are adenocarcinomas. They can grow as space-filling 
processes or diffusely infiltrate the stomach wall (linitis plastica). Non-
Hodgkin lymphoma and leiomyosarcoma are malignant gastric tumors. 
Nitrates in food, which are converted to carcinogenic nitrites by bacteria, 
play an important role in the development of the gastric carcinoma. Hp 
infection also seems to play a significant role. Patients with chronic atro-
phic type A gastritis are at particular risk for carcinoma. Gastric carcinomas 
are more frequent in patients with blood group A. 
Clinical Features. In contrast to ulcers, the symptoms of gastric carci-
noma are less typical. They start slowly, are uncharacteristic, and are not peri-
odic. There is generally no history of stomach complaints. Typical features are 
the persistence or progression of the complaints and the appearance of general 
symptoms, particularly weakness (anemia) and weight loss. Iron-deficiency 
anemia frequently precedes the local symptoms by weeks or months. In con-
trast to ulcer symptoms, carcinoma pain is not relieved by antacids and is not 
periodic. In about one-quarter of cases there is no pain, but rather unspecific 
complaints (feeling of fullness, discomfort, belching, nausea). In other cases the 
complaints are more diffuse, e. g., loss of appetite andweight loss. Vomiting is 
typical for tumors in the antrum or cardia. Cardiac carcinoma extending to the 
esophagus typically causes dysphagia. 
Diagnosis. The carcinoma is generally palpable only in advanced cases. The 
early cases are either not sensitive to palpation or present with diffuse pain. A Vir-
chow gland above the left clavicle is typical for advanced gastric carcinoma. 
Endoscopy and histology are usually diagnostic. If endoscopy suggests 
gastric carcinoma, a negative biopsy does not rule out a carcinoma. Close endo-
scopic−histologic monitoring is necessary for early detection of gastric carci-
noma. Failure of an ulcer to heal after four to eight weeks of medical therapy or 
early recurrence are indications for a malignant or complicated ulcer. 
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Detection of early cancer by endoscopy improves prognosis. Early can-
cer, defined as carcinoma restricted to mucosa and submucosa, is generally 
cured bysurgery. 
Rare Gastric Diseases. Malignant Lymphoma. Malignant lymphoma is 
similar to gastric carcinoma. Primary gastric lymphoma is rare. 
However, the stomach is the most common extranodal localization of a 
non-Hodgkin lymphoma. The prognosis of malignant lymphoma is signifi-
cantly better than that of gastric carcinoma. Infection with Hp is associatedwith 
the development of gastric lymphoma, particularly the MALT lymphoma. The 
eradication of the Hp infection causes a regression of the MALT lymphoma in 
about 50% of patients. 
Lymphoma of the small intestine can also be a complication of sprue. 
Leiomyoma. This tumor is rare (approximately 1% of all tumors). The 
most important clinical symptom is hemorrhage. Endoscopy and radiography 
show a semispherical, well-circumscribed tumor with central ulceration. 
Gastrointestinal Stroma Tumors (GIST). GIST are mesenchymal tumors 
of the gastrointestinal tract, 60−70% of which are localized in the stomach. 
They were until recently frequently classified as leiomyomas or leiomyosarco-
mas, but have a specific cellular origin and a specific pathogenesis. GIST are 
identified by mutations of the cKIT protooncogene and activation of the KIT 
receptor tyrosine kinase, and like chronic lymphatic leukemia, respond to 
treatment with the specific tyrosine kinase inhibitor imatinib mesylate. 
Intestinal Polyposis. In contrast to Menetrier disease, gastric mucosa 
with intestinal polyposis shows a predominantly normal, smooth aspect with 
diffusely distributed individual polyps at endoscopy. Gastric polyps are more 
frequent in patients with chronic atrophic gastritis, particularly in pernicious 
anemia. The complaints are uncharacteristic. Depending on the extent and loca-
tion of the tumors, the polyps may be asymptomatic, may present as gastritis, or 
result in sudden stenosis. The tumors often bleed, resulting in anemia that may 
dominate the clinical picture. The diagnosis must be histologically confirmed. 
Hamartomatous polyps occur in the colon and the small intestine in 
Peutz−Jeghers syndrome and juvenile polyposis. Malignancy is rare compared 
to familiar adenomatous polyposis, Gardner and Turcot syndromes, and heredi-
tary nonpolyposis colorectal carcinoma.  
Very Rare Gastric Diseases. Syphilis, tuberculosis, sarcoidosis, Crohn 
disease, eosinophilic gastritis, or phlegmonous gastritis are extremely rare 
causes of gastric complaints. Endoscopy and biopsy are generally diagnostic. 
With many diseases the diagnosis can only be confirmed if organs other than 
the stomach are affected (e. g., sarcoidosis, Crohn disease, tuberculosis). 
Duodenal Diverticulitis. Duodenal diverticulitis is generally harmless. 
Sometimes, however, it may cause complaints similar to duodenal ulcers. An-
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nular pancreas must be considered in the differential diagnosis. Periampullar or 
intraduodenal diverticula originating from the common bile duct may be a rare 
cause of pancreatitis or cholangitis. 
Complaints after Gastric Surgery. The following diseases may be en-
countered in patients after stomach resection: 
Preexisting Disease. The preexisting disease was not detected and con-
tinues to cause problems after surgery (e. g., IBS, porphyria). 
Jejunal Peptic Ulcer. After stomach resection ulcers recur mostly at the 
anastomosis or immediately distal in the small intestine. The complaints depend 
on food intake (mostly late pain) and show a periodic course. 
The pain is primarily localized to the left and is only poorly relieved by 
antacids. Continuous pain as a result of penetration or hemorrhage is a frequent 
complication.  
Carcinoma of the Gastric Stump. Increased occurrence of cancers can be 
expected 15−20 years after gastric resection.  
Dumping Syndrome. Fast evacuation of the stomach and hypertonic nu-
trition cause early dumping syndrome. The accumulation of hypertonic solu-
tions (particularly sugar) in the jejunum leads to inflow of fluids from the ex-
tracellular space into the jejunum and to reduced plasma volume. The disten-
sion of the jejunum triggers autonomic reflexes and causes dumping syndrome. 
The signs start during or immediately after a meal with discomfort and signs of 
hypovolemia, i. e., sudden onset of weakness, dizziness, sweating, tachycardia, 
shaking, and paleness. Distribution of food intake over several small meals, 
reduction of fluid intake while eating, avoiding hypertonic food, and, in some 
cases, lying down immediately after meals, can generally prevent symptoms. 
Dumping syndrome is diagnosed primarily from the medical history. It is only 
observed after surgery for duodenal ulcers with pyloric resection (i. e., not after 
proximal selective vagotomy without pylorus surgery). 
Late dumping syndrome presents similarly, but occurs 1.5−3.0 hours af-
ter meals and is caused by reactive hypoglycemia. 
Sudden evacuation causes postprandial hyperglycemia followed by reac-
tive hypoglycemia. In contrast to early dumping syndrome the symptoms are 
relieved by eating, particularly sugar. 
Leading Loop Syndrome. Recurring pain in the epigastric region 
combined with vomiting (bile with or without food) is observed with this 
rare postoperative complication, particularly after Billroth II operation. A 
feeling of fullness occurs 20−60 minutes postprandial and is often followed 
by nausea and vomiting. Blind loop syndrome, which includes stasis and 
bacterial colonization in the region of the blind loop of the small intestine, 
also belongs to this group of disorders. 
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Bile Acid Reflux Gastropathy (Alkaline Reflux Gastropathy). 
This is associated with an early feeling of fullness, abdominal pain, and 
vomiting.  
Postvagotomy Diarrhea. This occurs particularly after truncal vago-
tomy. 
Deficiency Symptoms (Including Agastric Syndrome). The symptoms 
are: protein deficiency, iron deficiency (common), pernicious anemia (rare), 
and general symptoms of vitamin deficiency (osteomalacia, particularly after 
gastrojejunostomy or Billroth II operation). 
 
Pain Originating from the Colon 
Irritable Bowel Syndrome (IBS). Definition. More than 50% of pa-
tients with chronic recurring abdominal pain suffer from an irritable colon. 
This disorder is not restricted to the colon and is better named irritable 
bowel syndrome (IBS). IBS is a syndrome of unexplained etiology, character-
ized by disordered motility and secretion, primarily in the colon, and by the 
lack of a detectable organic cause. There are a number of older and newer terms 
for the varied symptoms of chronic abdominal pain with no organic cause (e. 
g., dyspepsia, nonulcerous dyspepsia, gastritis, functional dyspepsia, hyperacid-
ity complaints), which, depending on the main symptoms, can be termed irrita-
ble stomach or IBS. 
Clinical Features. Intermittent abdominal pain of variable intensity and 
changing location, combined with stool problems (diarrhea, constipation, or 
both alternating), are clinically detectable. Chronic constipation or diarrhea 
without organic cause may be variations of IBS. They differ from IBS by the 
absence of pain. Patients with IBS often consult the physician because of an 
acute exacerbation of the complaints. A detailed medical history of similar 
earlier episodes is important for the correct interpretation of the acute event.  
Important information from the medical history could be an appendectomy due 
to “chronic appendicitis” (i. e., surgery after 1 or 2 weeks of pain). 
The pain with IBS varies from an unpleasant feeling of pressure and 
bloating to severe abdominal colic. The localization of the pain is highly 
variable, ranging from the hypogastric and midabdominal regions to the left 
and right, or diffusely throughout the entire abdomen, and thus imitates dis-
eases of the abdomen and the chest. A long history with similar episodes of 
pain and no periodic pain is an important characteristic. The pain can some-
times mimic an acute abdomen. 
Dyspeptic complaints (e. g., nausea, feeling of fullness, primarily post-
prandial, bloating, flatulence) are frequent accompanying symptoms. The ma-
jority of patients suffer simultaneously from multiple other functional disor-
ders. Laxative use is common. 
 18 
Subgroups of These Symptoms. Abnormal mucous content in the stool or 
isolated evacuation of sausage-skinlike membranes combined with abdominal 
colic are typical for mucous colitis, which is a subcategory of IBS. Proctalgia 
fugax is also a subcategory of IBS. It is a syndrome characterized by episodes 
of very severe cramplike pain in the rectum and perineal region, that last from a 
few minutes to an hour and usually occur during the day (DD: coccygodynia). 
The cause here is also unclear and no organic cause can be found (tentative 
therapy: nitrates or calcium antagonists).  
Diagnosis. Clinical examinations are typically normal in IBS. The 
physical condition is good with stable weight. Laboratory tests are normal. No 
occult blood and no parasites can be found in the stool (repeated checks). 
The colon can often be palpated in the left hypogastric region as a con-
tracted structure (cordon iliaque). Sometimes endoscopic examination shows a 
slightly reddened mucosa covered with mucous. Endoscopy often triggers 
spasms. Endoscopy and radiography are typically normal. 
Differential Diagnosis. IBS is a diagnosis by exclusion (e. g., carcinoma, 
ulcer, diverticulitis, cholelithiasis, nephrolithiasis, gynecologic conditions, 
Crohn disease, sprue, lactose intolerance, collagen colitis, parasites [giardiasis], 
depression, etc.). The individual diagnostic steps are primarily based on clinical 
experience. The shorter the history and the older the patient the less likely is 
IBS. On the other hand a young patient, long history, good physical condition, 
and constant body weight are suggestive of IBS. IBS and duodenal ulcer or 
cholelithiasis may possibly coexist. Diverticulitis must always be considered in 
older patients. Pneumatosis cystoides intestinalis is characterized by subserous 
or submucosal gas-filled cysts in the gastrointestinal tract, that can be visual-
ized by plain radiography. All sections of the intestine can be affected. In 85% 
of cases the pneumatosis is associated with other gastrointestinal diseases (py-
loric stenosis, appendicitis, regional enteritis, colitis, anal fistula). The clinical 
symptoms are uncharacteristic. Hemorrhage is rare. 
 
Pain Originating from Bile Ducts and Liver 
In differential diagnosis of pain in the epigastrium complaints originat-
ing from the bile ducts must always be considered. 
The most important symptoms that indicate a biliary disease are: epi-
sodic pain in the epigastric region with or without radiation to the right shoul-
der, acute exacerbation of the pain over 1−3 days, nausea, vomiting, and occa-
sional jaundice, with pain-free intervals often lasting weeks to months. 
Cholelithiasis. Clinical Features. So-called gallstone colic is generally 
triggered by food intake. After a few minutes the pain reaches its peak and can 
be extremely intense. It is generally clearly different from the pain associated 
with duodenal ulcers, which increases slowly and is rarely as severe. The term 
“colic” is not always accurate, because it is generally a severe continuous pain, 
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lasting for several hours. The pain is not always circumscribed, is most intense 
below the right ribs but can also be localized along the mid-line. Radiation to 
right back and the right shoulder is typical. Nausea is an almost obligatory 
accompanying symptom. Fat intolerance is very common. Fat intolerance 
alone, however, without painful colic, is very common and unspecific. Exami-
nation during the pain episode usually reveals an intensive, sometimes only 
low-grade, sensitivity to palpation in the gall bladder region and a low-grade 
defense in the right epigastric region. 
Epidemiology. Cholelithiasis affects women about twice as often as 
men. Predisposing factors are pregnancy, obesity, diabetes, and increasing age. 
The majority of patients with gallstones show no or atypical symptoms, particu-
larly symptoms of IBS. In Europe and America gallstones are mostly choles-
terol stones (two-thirds not radio-opaque, about one-third with calcification). 
Pigmented gallstones are more frequent in Japan, whereas in the 
West they are found mostly in patients with hemolytic anemia, particularly 
with congenital spherocytosis and sickle cell anemia. Patients with cirrhosis 
of the liver also have an increased incidence of pigmented stones for un-
known reasons. 
Differential Diagnosis. In general, gallstone colic is so typical that it 
is easily diagnosed. The following must be excluded in differential diagno-
sis: right-sided kidney colic, thromboses of mesenteric veins or arteries, 
acute inflammation of a dorsally and cranially placed appendix, duodenal 
ulcer, hepatitis, and pancreatitis, which is often caused by biliary obstruc-
tion. Epigastric and umbilical hernias are also rare causes of pain. Myocar-
dial infarction and right-sided heart failure with acute congestion of the 
liver are two diseases of organs outside of the abdomen that may mimic 
gallstone colic. An acute perihepatitis, which is mostly observed in young 
women, can easily be misinterpreted as cholelithiasis. 
Diagnosis. Sonography is the method of choice to confirm cholecys-
tolithiasis. Stones are a frequent finding at sonography of patients with 
atypical or no biliary symptoms. Calcium-containing stones are detected by 
plain radiography. Choledochus stones can be detected by ERCP. It is as-
sumed that 10% of patients with gallbladder stones also have choledochus 
stones. The symptoms vary. Typical is either an intermittent obstructive 
jaundice, mostly in connection with a pain attack, pancreatitis, or cholangi-
tis. However, many patients have no or only minor symptoms. In contrast to 
cholecystolithiasis, biliary colic with choledocholithiasis is often associated 
with vomiting. About three-quarters of all patients with choledocholithiasis 
have pain, which is virtually indistinguishable from that of cholecystolithi-
asis with respect to localization, severity, and radiation. 
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Complaints after Cholecystectomy. If symptoms continue or recur af-
ter cholecystectomy, which occurs in 10−15% cases, the following three possi-
bilities must be considered: 
 extrabiliary causes of the complaints, which were present beforehand 
and were not corrected by the cholecystectomy 
 symptoms originating from the bile ducts, which were overlooked 
during the surgery (e. g., choledocholithiasis) 
 surgical complications in extrahepatic bile ducts (e. g., postoperative 
strictures, fistulas, ligation or transsection of the bile duct). 
Symptoms persisting after cholecystectomy, particularly after removal 
of a stone-free gall bladder, frequently indicate an underlying extrabiliary prob-
lem (e. g., pancreatitis, ulcer, carcinoma, IBS, etc). 
Choledochus Stones and Papillary Stenoses. Choledochus stones or 
papillary stenoses are the two most common causes of persistent symptoms 
after cholecystectomy. 
Diagnosis is based on the biochemical confirmation of intermittent ob-
struction (increase of alkaline phosphatase with normal bilirubin), best done 
immediately after a pain attack. Often a transient hyperamylasemia can be 
detected. The diagnostic method of choice is ERCP. In choledocholithiasis an 
endoscopic papillotomy is frequently required to remove the stones. 
If obstruction of the common bile duct by a process in the head of the 
pancreas exists (pancreatitis, carcinoma) additional studies are required: sono-
graphy, endosonography, CT and cholangio-MRI. 
A long cystic stump after cholecystectomy rarely causes clinical symp-
toms, unless new gallstones are formed. 
 
Differential Diagnosis of Pain in the Right Hypogastric  
and Midabdominal Region 
Biliary and Extrabiliary Causes. Differential diagnosis must include, 
in addition to biliary causes, duodenal ulcers, pancreatitis, hepatopathies 
(alcohol-induced hepatitis, congestion of the liver, space occupying proc-
esses), parasites (e. g., Fasciola hepatica), acute perihepatitis, renal affec-
tions, neoplasm of liver, bile ducts, pancreas, duodenum, kidneys, colon, 
and a radicular pain syndrome from the back. Metabolic diseases, colla-
genosis, and pain from vascular causes must also be considered. Indistinct 
pressure sensations occasionally occur with the rare Chilaiditi syndrome, 
which is characterized by the interposition of the colon in the right hypo-
chondriac region between the liver and the diaphragm. This syndrome must 
not be misinterpreted as free intraabdominal air. 
Functional Complaints. Differentiation between bile duct dyskinesia 
(functional motility disorders) and physical obstruction (primarily adeno-
myomatosis in the cervical region of the gall bladder) is not possible by 
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clinical examination. Dyskinesia is probable when other functional com-
plaints are present. 
 
Diseases of the Pancreas 
Clinical Features. The main clinical symptoms that indicate disease of 
the pancreas are: 
 pain 
 cholestasis 
 weight loss 
 diabetes mellitus 
 diarrhea/steatorrhea. 
Chronic Pancreatitis 
Causes. Chronic pancreatitis is characterized initially by recurring epi-
sodes of pancreatitis and later by exocrine and endocrine pancreatic insuffi-
ciency. The primary cause of chronic pancreatitis in more than 60% of cases is 
alcohol use. Other cases have no clear cause or the causes are rare (e. g., pan-
creatic duct obstruction, hyperparathyroidism, hyperlipidemia, trauma, analge-
sic use, or hereditary). Mutations of the gene for cationic trypsinogen can cause 
the rare hereditary pancreatitis. Mutation of the gene for the cystic fibrosis 
transmembrane conductance regulator (CFTR), also without any clinical signs 
of a cystic fibrosis, or of the serine protease inhibitors Kazal type 1 (SPINK1) 
are associated with some cases of chronic pancreatitis that were formerly classi-
fied as idiopathic. Cholelithiasis rarely causes chronic pancreatitis. 
Epidemiology. Men are affected approximately seven times more often 
than women. 
Clinical Features. Approximately 10−20% of patients with chronic pan-
creatitis have no pain, particularly in nonalcoholic chronic pancreatitis (idio-
pathic-senile form, hyperparathyroidism, analgesic use). Diabetes mellitus or 
steatorrhea is generally the first clinical manifestation. Local complications (e. 
g., obstructive jaundice) are rarely caused by chronic pancreatitis. 
Chronic pancreatitis in the early stage presents typically with episodic 
attacks of epigastric pain followed by weeks or months without pain. Continu-
ous pain over weeks, particularly postprandial or recurring at short intervals, 
indicates local complications, particularly pseudocysts. Elevated pressure in 
dilated pancreatic ducts often causes continuous pain. Local complications can 
be diagnosed by sonography, endosonography, CT, MRT, or ERCP. A pancre-
atic carcinoma must always be considered. In older patients with continuous 
pain for less than 18 months, weight loss, and no history of pancreatitis, a pan-
creatic carcinoma is more probable than chronic pancreatitis. 
The pain episode in chronic pancreatitis is clinically and biochemically 
virtually identical to acute pancreatitis. Spontaneously occurring, continuous 
pain in the epigastrium, persisting for hours to a few days and often associated 
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with vomiting and subileus, is characteristic. The intensity of the pain is very 
variable and ranges from mild stomach discomfort to very severe pain with the 
feeling of dying.  
Weight loss of 5−10 kg or more is almost always associated with chronic 
pancreatitis and generally occurs in the early stages of the disease, before dia-
betes mellitus or steatorrhea develop. 
Chronic pancreatitis always leads to diabetes mellitus, generally within three 
to five years, and can be diagnosed by an oral glucose tolerance test. Pancreato-
genic diabetes must be suspected especially in younger, non-obese patients without 
family history and with a history of recurring abdominal pain or alcohol use. 
Persistent meteorism may indicate chronic pancreatitis. Diarrhea and 
steatorrhea generally develop later. Fatty stools, not occuring otherwise, are 
pathognomonic for pancreatogenic steatorrhea. Steatorrhea is a later complica-
tion. With the development of pancreatic calcifications, diabetes, and severe 
exocrine pancreatic insufficiency the pain generally disappears spontaneously 
unless there are local complications (burntout pancreatitis). 
Diagnosis. Early exocrine pancreas insufficiency can only be detected by rela-
tively complex function tests. Pancreatic calcifications can be detected in > 60% of 
patients by plain radiography. Stones are formed primarily in the pancreatic duct 
system and are detected by sonography, endoscopy, CT or ERCP. 
Various imaging procedures are used for the assessment of pancreatic 
diseases. Sonography, as well as endosonography and CT, are very useful for 
diagnosis and monitoring of acute pancreatitis, for detection of pseudocysts, 
cholelithiasis, pancreatic carcinoma, and in cholestasis/jaundice. ERCP and 
magnetic resonance cholangiopancreaticography (MRCP) are primarily used in 
etiologically unclear, recurring pancreatitis and local complications of pan-
creatitis. In early chronic pancreatitis imaging procedures are of limited value, 
in particular in differentiating acute pancreatitis. 
Complications. Local complications of chronic pancreatitis are common: 
pseudocysts, pancreatogenic ascites, cholestasis with or without jaundice, 
thrombosis of the splenic veins, duodenal stenosis, gastrointestinal hemorrhage, 
and stenoses or fistula formation in the colon. Many of these local complica-
tions also occur with acute pancreatitis. 
Differential Diagnosis of Pancreatic Carcinoma. Differential diagnosis 
of chronic pancreatitis versus carcinoma of the head of the pancreas can be very 
difficult. Positron emission tomography (PET) may be helpful. Nevertheless, it 
is often not possible, even during surgery, to decide whether a small pancreatic 
carcinoma with accompanying pancreatitis or chronic pancreatitis only is pre-
sent. With the exception of papillary carcinoma, which causes obstructive jaun-
dice very early and has a good prognosis with radical surgery, the prognosis for 
pancreatic carcinoma is very poor.  
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Pancreatic Carcinoma. Epidemiology and Localization. The symptoms 
of pancreatic carcinoma are unspecific. This diagnosis must always be consid-
ered in older patients with abdominal pain without evidence of gastric or he-
patic disease (average age 55 years, men affected twice as often as women). 
Risk factors for pancreatic carcinoma are poorly defined. Heavy smokers seem 
to be affected more often than nonsmokers. More than 90% of pancreatic carci-
nomas are ductal adenocarcinomas. Islet cell carcinomas represent only a small 
proportion. Pancreatic carcinoma occurs in the head of the pancreas in about 
70% of cases, in the body in 20%, and rarely in the tail. The clinical symptoms 
vary depending on the size and localization of the tumor. 
Clinical Features and Diagnosis. Carcinoma of the pancreas head is 
primarily characterized by periampullar localization with the triad of pain, 
weight loss, and progressive obstructive jaundice with dark urine, acholic stool, 
and pruritis. An enlarged, palpable gall bladder (Courvoisier sign, > 50% of 
cases) indicates distal choledochus obstruction. Painless obstructive jaundice is 
found in about 25% of patients. Dilated bile ducts can usually be visualized by 
sonography. Diagnosis generally requires ERCP and/or biopsy guided by sono-
graphy, endosonography or CT. Percutaneous biopsy should be avoided in 
resectable tumors because of the risk of needle tract metastases. Positron emis-
sion tomography (PET) can be useful here to differentiate between inflamma-
tory and neoplastic processes. 
Pain and weight loss without jaundice are initial symptoms for nonpapillary 
carcinomas. The pain, initially intermittent, later continuous, is localized in the 
epigastric region, primarily to the left and typically radiates to the back. 
Increased pain when lying down, and improvement when standing and 
bending forward, is typical, similar to chronic pancreatitis. Pancreatitis epi-
sodes resulting from duct obstruction may be the first manifestation of a pan-
creatic carcinoma. Signs of poor assimilation, particularly diarrhea, steatorrhea, 
and weight loss, may precede other manifestations of the tumor by months. 
Thrombophlebitis migrans is present in < 10% of cases. A pancreatic 
carcinoma or an acute pancreatitis is rarely the cause of panniculitis nodularis 
(Pfeifer−Weber−Christian syndrome). 
Amylase and lipase are almost always in the normal range. The oral glu-
cose tolerance is pathologic in 30−50% of cases. Exocrine pancreatic insuffi-
ciency can generally be detected with carcinoma of the pancreatic head. CEA 
and CA19−9 are frequently elevated, with the latter being relatively specific for 
pancreatic carcinoma.  
 
Functional abdominal pain syndrome (FAPS) 
A special attention should be paid at functional abdominal pain syn-
drome (FAPS). FAPS is a distinct medical disorder. Evidence suggests that the 
syndrome relates to central nervous system (CNS) amplification of normal 
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regulatory visceral signals, rather than functional abnormalities in the gastroin-
testinal tract. The disorder is characterized by continuous, almost continuous, or 
at least frequently recurrent abdominal pain that is poorly related to bowel 
habits and often not well localized. FAPS is properly understood as abnormal 
perception of normal (regulatory) bowel function rather than a motility disor-
der. The syndrome appears to be closely related to alterations in endogenous 
pain modulation systems, including dysfunction of descending and cortical pain 
modulation circuits. The Rome III diagnostic criteria for FAPS are shown in 
Table 2. Studies that included patients who meet diagnostic criteria for FAPS 
have revealed that only rarely is an organic cause of chronic abdominal pain 
found during long-term follow-up. 
FAPS is commonly associated with other unpleasant somatic symptoms, 
and, when it persists or dominates the patient's life, it usually is associated with 
chronic pain behaviors and comorbid psychological disturbances. Patients with 
FAPS typically define their illness as medical, and their symptoms tend to be 
more severe and associated with greater functional impairment than those of 
patients with IBS. Psychological disturbances, if present, must be considered as 
comorbid features of FAPS rather than as part of a primarily psychiatric prob-
lem. When compared with patients who have chronic back pain, those with 
chronic abdominal pain report significantly better physical functioning 
 
Table 2    
Rome III Criteria for Functional Abdominal Pain Syndrome 
 
Must include all the following:  
   1.    Continuous or almost continuous abdominal pain 
   2.    No or only occasional relationship of pain with physiologic events (e.g., eating, defecation, menses) 
   3.    Some loss of daily functioning 
   4.    Pain is not feigned (e.g., no malingering) 
   5.    Insufficient symptoms to meet criteria for another func-tional gastrointestinal disorder that would explain the pain  
*Criteria fulfilled for the past three months with symptom onset at least six 
months prior to diagnosis. 
 
Epidemiology. In the U.S. Householder Survey of Functional Gastrointes-
tinal Disorders, FAPS was estimated to be present in 2% of the sample and was 
less frequent than IBS (9%). A female predominance was noted (F:M = 1.5). 
Patients with FAPS missed more work days because of illness and had more 
physician visits than those without abdominal symptoms. A substantial propor-
tion of patients are referred to gastroenterology practices and medical centers; 
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they have a disproportionate number of health care visits and often undergo 
numerous diagnostic procedures and treatments.  
Pathophysiology. Chronic pain is a multidimensional (sensory, emo-
tional, cognitive) experience explained by abnormalities in neurophysiologic 
functioning at the afferent, spinal, and CNS levels. Unlike acute pain arising 
from peripheral or visceral injury or disease, chronic functional pain is not 
associated with increased afferent visceral stimuli from structural abnormalities 
and tissue damage. FAPS is considered what is termed a biopsychosocial dis-
order related to dysfunction of the brain-gut axis. Clinical expression of FAPS 
is derived from psychological and intestinal physiologic input that interacts via 
the CNS-gut neuraxis. This model integrates the clinical, physiologic, and psy-
chosocial features of FAPS into a comprehensible form, providing the basis for 
understanding psychological influences and application of psychopharma-
cologic treatments.  
Research relating to the pathophysiology of painful functional gastroin-
testinal disorders has focused on the concepts of visceral hypersensitivity and 
alterations of brain-gut interactions. Visceral hypersensitivity is facilitated by 
up-regulation of mucosal nociceptors and sensitization of visceral afferent 
nerves. Dysregulation of the brain-gut axis can be manifested as central en-
hancement of afferent visceral signals. The brain-gut dysregulation can, in turn, 
be initiated or modified by a variety of events. I 
n a large-scale, prospective, controlled investigation of the development 
of chronic abdominal pain in women undergoing gynecologic surgery for non-
painful indications, pain developed significantly more frequently in the surgical 
group (15%) than in a nonsurgical control group (4%). The development of 
chronic abdominal pain in the postoperative setting was predicted only by psy-
chosocial, and not surgical, variables, implying that the development of pain is 
associated closely with central registration and amplification of the afferent 
signal. This study lends strong support to the biopsychosocial model, docu-
menting the importance of cognitive and emotional input during the develop-
ment of postoperative FAPS.  
Ascending Visceral Pain Transmission. The afferent transmission of 
visceral abdominal pain involves first-order neurons that innervate the viscera, 
carry information to the thoracolumbar sympathetic nervous system, and sub-
sequently synapse in the dorsal horn of the spinal cord.  
Second-order neurons cross and ascend from the dorsal horn via the spi-
nothalamic and spinoreticular tracts. These second-order neurons synapse in the 
thalamus with third-order neurons that synapse with the somatosensory cortex 
(sensory-discriminative component), which is involved in the somatotypic or 
point-specific localization and intensity of afferent signals, and with the limbic 
system (motivational-affective component), which contains the anterior cingu-
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late cortex. The insular cortex receives input from the sensory thalamus and the 
nucleus tractus solitarius and integrates visceral sensory and emotional infor-
mation. The limbic system serves as a modulator of the pain experience, based 
on the individual's emotional state, prior experiences, and cognitive inter-
pretation of the signal. This multicomponent integration of nociceptive 
information in the CNS explains the variability in the experience and re-
porting of pain. Motivational-affective regions of the CNS are important 
contributors to the chronic pain experience by modulating afferent sensory 
information from the intestine.  
This conceptual scheme of pain modulation has been demonstrated 
through PET imaging with the use of radiolabeled oxygen. In a group of 
healthy subjects who immersed their hands in hot water, half were hypnotized 
to experience the immersion as painful and the other half as not painful or even 
pleasant. The changes in cortical activation were compared between the two 
groups, and no difference was found in activity in the somatosensory cortex; 
however, those who experienced pain had significantly greater activation of the 
ACC of the limbic system, which is involved in the affective component of the 
pain experience.  
Functional brain imaging studies comparing patients with functional 
gastrointestinal disease and normal controls have shown abnormal brain activa-
tion mainly in the motivational-affective pain regions, including the prefrontal 
cortex, ACC, amygdala, and insula. These regions generally show increased 
activation in patients with chronic pain, thereby suggesting abnormal afferent 
input as well as central modulation, which could be caused in part by increased 
attention to visceral stimuli, abnormal cognitive or affective processing of af-
ferent input, or comorbid psychiatric disorders.  
Descending Modulation of Pain. Afferent transmission of visceral pain 
can be modulated by descending impulses from the cortex down to the visceral 
nerves. In this model, the central descending control of the gating system oc-
curs primarily through the descending inhibitory system. This system is an 
endorphin- or enkephalin-based neural network that originates from the cortex 
and limbic system and descends to the spinal cord, with major links in the mid-
brain (periaqueductal gray) and medulla (caudal raphe nucleus).  
This system inhibits nociceptive projection directly on the second-order 
neurons or indirectly via inhibitory interneurons in the spinal cord. Then, the 
dorsal horn of the spinal cord acts as a gate to modulate (i.e., increase or de-
crease) transmission of afferent impulses from peripheral nociceptive sites to 
the CNS. In effect, this descending pain modulation system determines the 
amount of peripheral afferent input from the gut that is allowed to ascend to the 
brain. Descending inhibitory systems can be diffuse and, when activated, in-
hibit pain sensitivity throughout the body–so-called diffuse noxious inhibitory 
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control (DNIC). Patients with chronic pain syndromes, including FAPS, appear 
to have an impaired ability to activate DNIC.  
Visceral Sensitization. Recurrent peripheral stimulation is thought to 
up-regulate afferent signals or inhibit descending pain control mechanisms, 
thereby sensitizing the bowel and producing a state of visceral hyperalgesia 
(increased pain response to a noxious signal) and chronic pain. Several clinical 
studies have supported this concept, and the increase in pain appears to occur to 
a greater degree in patients with functional gastrointestinal disorders than in 
healthy subjects. Furthermore, preoperative treatment with local or regional 
anesthesia or NSAIDs reduces the severity of postoperative pain, suggesting 
that the CNS response to peripheral injury can be modified by prior reduction 
of afferent input to the spinal cord and CNS.  
Conversely, recurrent peripheral injury, such as repeated abdominal op-
erations, may sensitize intestinal receptors, thereby making perception of even 
baseline afferent activity more painful (allodynia). Visceral sensitization may 
develop through different mechanisms at one or more levels of the neuraxis, 
including the mucosal level (via afferent silent nociceptors) and spinal level 
(spinal hyperexcitability). Patients with IBS may also experience hyperal-
gesia. Studies of rectal balloon distention in patients with IBS have demon-
strated that a greater proportion of patients report discomfort to balloon 
distention than normal volunteers at a given volume of inflation; in addi-
tion, the intensity of the discomfort in patients is higher than in the normal 
volunteers. Rectal hypersensitivity induced by repetitive painful rectal dis-
tention is seen in patients with IBS, but not FAPS. This observation sup-
ports the contention that IBS and FAPS are distinct functional gastrointesti-
nal disorders.  
Biochemical Mechanisms of Sensitization. The biochemical basis of 
visceral sensitization is under active study, and this research may identify fu-
ture targets for therapy. Serotonin (5-hydroxytryptamine [5-HT]) has received 
considerable attention because the gastrointestinal tract is its main source 
within the body. 5-HT is found primarily in mucosal enterochromaffin cells, 
where it appears to serve as a neurotransmitter of the enteric nervous system 
(ENS) and as a paracrine molecule that signals other (e.g., vagal) neural activ-
ity. 5-HT mediates numerous gastrointestinal functions, and modulation of 
various receptor subtypes, such as 5-HT1, 5-HT3, and 5-HT4, and of 5-HT reup-
take affects gastrointestinal sensorimotor function.  
Role of the Central Nervous System. Although peripheral sensitization 
may influence the onset of pain, the CNS is critically involved in the predispo-
sition to and perpetuation of chronic pain. In FAPS, the preeminent role of the 
CNS is evident by the lack of peripheral motor or sensory abnormalities and the 
strong association with psychosocial disturbances. In addition, comorbid psy-
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chiatric diagnoses, major life stressors, a history of sexual or physical abuse, 
poor social support, and maladaptive coping all are associated with more severe 
chronic abdominal pain and poorer health outcomes. These factors in patients 
with FAPS and other functional gastrointestinal pain conditions may impair or 
diminish descending inhibitory pain pathways that act on dorsal horn neurons 
or may amplify visceral afferent signals.  
Functional brain imaging has been useful in clarifying brain-gut in-
teraction and has demonstrated that links between emotional distress and 
chronic pain may be mediated through impairment in the ability of the 
limbic system to modulate visceral signals. The motivational-affective 
component of the central pain system, specifically the ACC, is dysfunc-
tional in patients with IBS and other chronic painful conditions. Func-
tional magnetic resonance imaging (MRI) and PET brain imaging in re-
sponse to rectal distention in patients with IBS have shown differential 
activation of the ACC in patients compared with normal subjects and 
increased activation of the thalamus.  
Similar results have been found in patients with a history of abuse, 
somatization, and post-traumatic stress disorder. Furthermore, the return of 
ACC activity to baseline in depressed patients is associated with clinical im-
provement and predicts response to antidepressant treatment. As the pain and 
emotional distress of a patient with IBS improve, the activity within the ACC 
changes correspondingly. The observed synergistic effect of IBS and abuse 
history on differential ACC activation suggests a mechanism to explain how 
afferent processing in the CNS can be associated with reporting of greater pain 
severity and poorer outcomes in this patient population. This and other research 
has suggested that dysregulation of central pain modulation is critical and may 
occur in various medical and psychological conditions. The challenge remains 
to alter this dysregulated afferent processing network reproducibly and to re-
verse the findings on functional brain imaging studies (by pharmacologic, psy-
chological, or other therapeutic means), with a concomitant improvement in 
patient outcomes.  
Clinical Implications. The concept of FAPS as a dysregulation of 
CNS–enteric nervous system function at varying levels of the neuraxis, 
rather than a purely psychiatric or structural gastrointestinal disorder, sug-
gests that chronic pain results from enhanced pain perception as a result of 
combinations of the following: (1) activation of silent nociceptors; (2) dor-
sal horn transmission of impulses stimulated by release of cytokines or 
other substances; and (3) chronic or frequently recurring psychosocial 
stresses that influence central pain modulation. By linking psychosocial 
factors to the pathophysiology of chronic abdominal pain, this conceptual 
scheme alters the therapeutic approach from one that is purely psychiatric 
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in nature to one that encompasses a broader array of potential therapies. 
Early pharmacologic and psychological treatment ultimately may be proven 
to prevent the development of a subsequent chronic pain syndrome.  
 
Clinical features 
History. Typically, patients with FAPS are middle-aged and female. 
The history is one of chronic abdominal pain, often for more than 10 years, and 
the patient is often in distress at the time of initial consultation. The pain is 
frequently described as severe, constant, and diffuse. Pain is often a focal point 
in the patient's life, may be described in emotional or bizarre terms (e.g., as 
nauseating or like a knife stabbing), and is not influenced by eating or defeca-
tion. The abdominal pain may be one of several painful symptoms or part of a 
continuum of painful experiences often beginning in childhood and recurring 
over time. FAPS sometimes coexists with other disorders, and the clinician 
must determine the degree to which one of these other conditions contributes to 
the FAPS. Frequently, FAPS will evolve in a patient who has had another well-
defined gastrointestinal disorder, but who has been operated on one or more 
times and, following these operations, has developed chronic abdominal pain. 
Repetitive surgery in such patients is often performed for alleged intes-
tinal obstruction caused by adhesions.  
Patients with FAPS often have a psychiatric diagnosis of anxiety, 
depression, or somatization. They may minimize the role of psychological 
factors, possibly having learned in childhood that attention is more likely 
received when reporting illness but not emotional distress. A history of 
unresolved losses is a common feature. Symptoms frequently worsen soon 
after these events and recur on their anniversaries or during holiday sea-
sons. A history of sexual and physical abuse is frequent and is predictive of 
poor health, refractoriness to medical care, and a high number of diagnostic 
and therapeutic procedures and health care visits. Because patients do not 
usually volunteer an abuse history, physicians should inquire about this 
possibility, particularly in those with refractory symptoms. 
Finally, patients with FAPS may report poor social networks and ex-
hibit ineffective coping strategies. They feel unable to decrease their symp-
toms and may “catastrophize” — that is, view their condition in pessimistic 
and morbid ways without any sense of control over the consequences. 
These cognitions are associated with greater pain scores that lead to a cycle 
of more illness reporting, more psychological distress, and poorer clinical 
outcomes. For many, the illness provides social support via increased atten-
tion from friends, family, and physicians.  
Patient Behavior. Certain behavioral traits are common in patients 
with FAPS. Often, these patients demand that the physician not only diag-
nose the problem promptly, but also relieve their chronic symptoms rapidly. 
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They similarly deny a relationship between their problem and psychologi-
cally disturbing issues and often attribute depression to pain rather than 
recognizing it as a primary factor. Frequently, an accompanying spouse or 
parent takes responsibility for reporting the patient's history, an observation 
that suggests the possibility of family dysfunction. A history of narcotic use 
is not uncommon, as is a request by the patient for such medication during 
the initial visit. This type of behavior reflects the patient's consideration of 
his or her situation as an acute condition requiring immediate symptom 
relief, rather than as a chronic condition in which treatment must be di-
rected toward enhancing coping and adaptive strategies.  
Physical Examination. Certain physical findings help support a diag-
nosis of FAPS, yet none is perfectly sensitive or specific. Abdominal palpation 
should begin at an area remote from the perceived site of maximal intensity. 
The patient's behavior during abdominal palpation should be noted, with an 
emphasis on whether a change is noted during distracting maneuvers. Patients 
with FAPS usually lack signs of autonomic arousal.  
The presence of multiple abdominal surgical scars without clearly 
understood indications may suggest chronic pain behaviors that have led to 
unnecessary procedures. The closed eyes sign may be noted; when the ab-
domen is palpated, the patient with FAPS may wince, with her or his eyes 
closed, whereas those with acute pain caused by organic pathology tend to 
keep their eyes open in fearful anticipation of the examination. Often, the 
stethoscope sign (i.e., gentle, distracting compression on a painful site of 
the abdomen with the diaphragm of the stethoscope), elicits a diminished 
behavioral response in a patient with FAPS, thereby affording a more accu-
rate appraisal of the complaint of pain.  
Diagnosis and differential diagnosis. After obtaining a complete 
history, performing a thorough physical examination, and paying appropri-
ate attention to psychosocial factors in the patient's life, the scenario will 
often point the physician toward a diagnosis of FAPS. A physical examina-
tion that does not suggest evidence of organic intra-abdominal pathology, 
as well as normal results of a battery of routine laboratory tests, lends sup-
port to the contention that the patient's pain is not the result of an identifi-
able structural disease.  
Recognition of the diagnostic criteria for FAPS, and failure to find evi-
dence of another cause of chronic abdominal pain, should lead the physician to 
a diagnosis of FAPS. If the features of FAPS are absent or atypical, or if con-
cerning abnormalities are found on physical examination (e.g., abdominal mass, 
enlarged liver) or on screening laboratory studies (e.g., anemia, hypoalbu-
minemia), another diagnosis should be considered and pursued accordingly. 
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Not uncommonly, nonspecific abnormalities are found (e.g., a liver cyst) and 
require determination of their relevance to the patient's symptoms. 
  
Treatment 
Establishing a Successful Patient-Physician Relationship. Once other 
diagnoses have been excluded, formation of a successful relationship between 
the physician and patient with FAPS is necessary for effective management. 
Several factors must be taken into account to help establish this relationship 
and move toward successful treatment. An understanding of the psychosocial 
background is helpful, because a detailed knowledge of this aspect of the pa-
tient's life aids in selecting the most useful treatment strategies. Having an 
appreciation of the degree of the patient's understanding of the illness is also 
important, particularly for enhancing the success of a treatment plan.  
Early in the development of the patient-physician relationship, it is 
important to determine whether there are abnormal illness behaviors and 
associated psychiatric diagnoses, which are often present in patients with 
FAPS. The role of the family in relation to the patient's illness should also 
be understood. Normally, family experiences with illness lead to emo-
tional support and a focus on recovery. With dysfunctional family interac-
tions, stresses are not managed in an optimal fashion, and diverting atten-
tion toward illness serves to reduce family distress.  Dysfunction is seen 
when family members indulge the patient, assume undue responsibility in 
the patient's management, or become the spokesperson for the patient. If 
such family dysfunction is observed, counseling may help the family de-
velop more useful coping strategies. Cultural belief systems must also be 
understood, because patients may not comply with treatments that are 
inconsistent with their cultural values. It is important to gain knowledge 
of the patient's psychosocial resources (i.e., the availability of social net-
works) that may assist in buffering the adverse effects of stress and im-
prove the outcome.  
It is essential for the physician to convey validation of illness to the pa-
tient by acknowledging the patient's illness and the effect it has had on his or 
her life in a nonjudgmental fashion. This step is important in ensuring that the 
patient understands that the physician considers FAPS to be a medical illness. 
Empathy is primary, because it acknowledges the reality and distress associated 
with the patient's pain. Providing an empathetic approach can provide benefit 
by improving adherence to a treatment plan, patient satisfaction, and clinical 
outcomes. It does not, however, equate with overreacting to the patient's wish 
for a rapid diagnosis and overmedication or performing unnecessary diagnostic 
studies. Education is provided by eliciting the patient's knowledge of the syn-
drome, addressing any concerns, explaining the nature of the symptoms, and 
ensuring understanding in all matters that have been discussed. It is helpful to 
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reiterate that FAPS is a medical disorder and that symptoms can be attenuated 
by pharmacologic or psychological treatments that modify the regulation of 
pain control. Reassurance should be provided, because patients may fear seri-
ous disease. After the evaluation is complete, the physician should respond to 
the patient's concerns in a clear, objective, and nondismissive manner. Both 
patient and physician must then negotiate the treatment.  
This approach will enable the patient to contribute to and take some re-
sponsibility for the treatment plan. Within the context of the patient's prior 
experience, interests, and understanding, the physician should provide choices 
rather than directives. Adherence to a treatment plan is more likely when the 
patient has confidence that it will benefit him or her and its rationale is under-
stood. Finally, the physician must set reasonable limits in relation to time and 
effort expended. The key to success is to maintain a trusting relationship, while 
setting proper boundaries.  
Instituting a Treatment Plan. Successful treatment rests on formulat-
ing a plan that encompasses ongoing interviews to ensure that the patient does 
not expect a cure. The physician should explain that a realistic treatment goal is 
to attenuate the symptoms and improve daily function. The patient should in-
crease his or her responsibility for the illness by identifying the circumstances 
surrounding episodes of pain, including emotional and cognitive responses. 
This technique helps the patient achieve insight into aggravating factors and 
also characterizes the patient's coping style. Such information helps identify 
a strategy for behavioral treatment. The treatment chosen should be based 
on the severity of symptoms and degree of associated disability. Symptoms 
that are intermittent and less severe and those that are clearly linked to psy-
chological distress are frequently amenable to psychological treatment. If 
the pain is continuous and severe, pharmacotherapy targeted to achieve 
central analgesia may be helpful.  
Pharmacotherapy. There is a paucity of evidence from prospective, 
randomized, controlled trials to support the use of drug therapy in FAPS. Drug 
development in the area of functional gastrointestinal disorders, particularly 
FAPS, has been slow. A major reason for this slow progress is the rather em-
pirical process for experimental testing that necessarily occurs in a symptom-
based syndrome. Pharmacologic brain imaging approaches hold promise as a 
means to accelerate drug discovery and subsequent development. Despite these 
limitations, some specific medications have been used in the treatment of FAPS 
(see later). Peripherally acting analgesics (e.g., acetaminophen, aspirin, other 
NSAIDs) offer little benefit to patients with FAPS, given the pathophysiology 
of the disorder (i.e., a biopsychosocial disorder related to dysfunction of the 
brain-gut neuraxis). Moreover, narcotics and benzodiazepines should not be 
prescribed for treatment of FAPS, because of the potential for increased pain 
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sensitivity and a lowering of the pain threshold, respectively. Furthermore, the 
omnipresent potential for drug dependency with these types of medications 
must be borne in mind. Importantly, prescribing such medications subordinates 
the development of more comprehensive treatment strategies to that of provid-
ing medication, can be counterproductive by leading to narcotic-induced poten-
tiation of visceral pain, and can thus result in the narcotic bowel syndrome. 
Narcotic bowel syndrome may occur in patients with other gastrointestinal 
disorders or in patients with no other structural intestinal disease who have 
been exposed to high doses of narcotic medication. The clinical scenario is 
dominated by chronic abdominal pain that continues to worsen, despite the use 
of escalating doses of narcotics. The keys to successful management of this 
disorder include the timely recognition of the syndrome followed by the estab-
lishment of an effective physician-patient relationship and graded tapering of 
the narcotic, with simultaneous institution of medical therapy to mitigate the 
effects of opiate withdrawal. 
As in the treatment of other chronic pain disorders, tricyclic antidepres-
sants (TCAs) can be helpful in FAPS. The benefit of these medications is de-
rived from their ability to improve pain directly and treat associated depression. 
In general, TCAs have been shown to be effective but can cause anticholinergic 
effects, hypotension, sedation, and cardiac arrhythmias. They can be given in 
dosages lower than those used to treat major depression (e.g., desipramine, 25 
to 100 mg/day at bedtime) to reduce side effects. However, dosage increases 
may be needed, particularly if the patient has psychiatric comorbidity. There is 
less evidence for the use of selective serotonin reuptake inhibitors (SSRIs) in 
FAPS. These medications may cause agitation, sleep disturbance, vivid dreams, 
and diarrhea but are much safer than TCAs if taken in an overdose. In most 
cases, administration of a single daily dose (e.g., 20 mg of fluoxetine, paroxet-
ine, or citalopram) will suffice. Although the efficacy of SSRIs for pain control 
is not well established, this class of drugs has additional benefits because they 
are anxiolytic and helpful for patients with social phobia, post-traumatic stress 
disorder, panic disorder, and obsessional thoughts related to their condition. 
Drug combinations (e.g., TCAs with SSRIs) have little support for their use in 
patients with functional gastrointestinal disorders. 
Anticonvulsants such as carbamazepine and gabapentin have been 
evaluated in other chronic pain syndromes but have no proven efficacy in 
FAPS. These drugs may find a role as adjunctive agents in the future. As is 
the case for other peripherally acting analgesics, topical capsaicin would 
not be expected to be helpful in the management of FAPS. Leuprolide ace-
tate may be of benefit for premenstrual females with FAPS, but the conse-
quent reproductive hormonal effects of this therapy have dampened enthu-
siasm for this approach.  
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To enhance compliance, especially in the case of TCA use, the physician 
should explain that these medications work as central analgesics and are not 
simply being used to treat a psychiatric condition. Investing the time to explain 
that these drugs induce neurotransmitter changes in the brain and thereby alter 
pain perception, and that the dosage is usually lower than that typically chosen 
for treatment of psychiatric disorders, is often helpful. Further, it may be bene-
ficial to emphasize that the lag time for clinical effect may be several weeks; 
most side effects diminish after a few days and can be reduced by temporarily 
lowering the dose of the drug.  
Mental Health Referral and Psychological Treatments. Patients may 
be reluctant to see a psychologist or psychiatrist because they lack knowledge 
of the benefits of referral, feel stigmatized for being thought to have a psychiat-
ric problem, or see referral as a rejection by the medical physician. Psychologi-
cal interventions are best presented as vehicles that are orchestrated in parallel 
with medical visits and are used to help manage pain and reduce the psycho-
logical distress caused by the symptoms.  
The mental health consultant may recommend any of several types of 
psychological treatments for pain management. Cognitive-behavioral treatment, 
which identifies maladaptive thoughts, perceptions, and behaviors, may be 
beneficial. Evidence from functional brain imaging suggests that this psycho-
logical intervention decreases activation from rectal stimulation in the central 
emotional regions that are typically hyperactive in chronic pain, such as the 
amygdala, ACC, and frontal cortex. Hypnotherapy has been investigated pri-
marily in IBS, where the focus is on relaxation of the gut. Hypnotherapy is 
superior to standard medical therapy in reducing pain at one year of follow-up. 
Dynamic or interpersonal psychotherapy and relaxation training have less evi-
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